Applied Imaging Shareholders OK Acquisition by Genetix | GenomeWeb
NEW YORK (GenomeWeb News) — Applied Imaging shareholders have approved the sale of the company to Genetix Group, AI said today.
 
As GenomeWeb News reported when the acquisition was announced in September, the all-cash deal is valued at $25.8 million. Genetix will pay $4.20 for each share of Applied Imaging's common stock.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.